FMS (Fresenius Medical Care AG) Total Receivables: $4,295 Mil (As of Mar. 2026)


FMS Fresenius Medical Care AG FMS
72 GF Score
Price $23.24
GF Value $24.15
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG Total Receivables?

Fresenius Medical Care AG FMS -0.04% 72 Total Receivables is $4,295 Mil as of Mar. 2026. GuruFocus rates FMS with a GF Score™ of 72/100 and a GF Value™ of $24.15 (Fairly Valued). The stock has 4 warning signs investors should review.

Fresenius Medical Care AG's Total Receivables for the quarter that ended in Mar. 2026 was $4,295 Mil.

Fresenius Medical Care AG Total Receivables Related Terms

Fresenius Medical Care AG Total Receivables Historical Data

* Premium members only.

The historical data trend for Fresenius Medical Care AG's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius Medical Care AG Total Receivables Chart

Fresenius Medical Care AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,414.33 4,279.37 4,428.18 4,105.62 4,282.60

Fresenius Medical Care AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,883.30 3,727.16 3,843.91 4,282.60 4,295.30
FMS
72GF Score
Fresenius Medical Care AG FMS
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius Medical Care AG Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $4,295 Mil mean?
Fresenius Medical Care AG (FMS) has a Total Receivables of $4,295 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Fresenius Medical Care AG and its competitors.
Is Fresenius Medical Care AG's Total Receivables too high?
Fresenius Medical Care AG's current Total Receivables is $4,295 Mil. Overall, Fresenius Medical Care AG has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Total Receivables compare to HCA and THC?
Fresenius Medical Care AG's Total Receivables of $4,295 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Healthcare Providers & Services company?
A good Total Receivables depends on the Healthcare Providers & Services industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Fresenius Medical Care AG and its competitors. Fresenius Medical Care AG's current Total Receivables is $4,295 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (FMS) is currently considered Fairly Valued. The stock's GF Value™ is $24.15, compared to a current price of $23.24 — trading 3.8% below its estimated fair value. The current Total Receivables is $4,295 Mil. Fresenius Medical Care AG's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Fresenius Medical Care AG (FMS), the current Total Receivables is $4,295 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius Medical Care AG (FMS) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued. The current stock price of $23.24 is trading 3.8% below its estimated GF Value™ of $24.15. GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.

Key valuation signals for FMS:

  • Total Receivables: $4,295 Mil
  • GF Value™: $24.15 vs. price of $23.24 (3.8% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the FMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
72GF Score

Get the complete analysis for FMS

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.24
Price
$24.15
GF Value